These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 9066944

  • 1. Drug interactions of macrolides: emphasis on dirithromycin.
    Watkins VS, Polk RE, Stotka JL.
    Ann Pharmacother; 1997 Mar; 31(3):349-56. PubMed ID: 9066944
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic drug interactions of macrolides.
    Periti P, Mazzei T, Mini E, Novelli A.
    Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin.
    Westphal JF.
    Br J Clin Pharmacol; 2000 Oct; 50(4):285-95. PubMed ID: 11012550
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.
    Shinkai I, Ohta Y.
    Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers.
    Lindstrom TD, Hanssen BR, Wrighton SA.
    Antimicrob Agents Chemother; 1993 Feb; 37(2):265-9. PubMed ID: 8452357
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin.
    Bachmann K, Nunlee M, Martin M, Sullivan T, Jauregui L, DeSante K, Sides GD.
    J Clin Pharmacol; 1990 Nov; 30(11):1001-5. PubMed ID: 2243147
    [Abstract] [Full Text] [Related]

  • 17. Macrolide antibacterials. Drug interactions of clinical significance.
    von Rosensteil NA, Adam D.
    Drug Saf; 1995 Aug; 13(2):105-22. PubMed ID: 7576262
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
    Biedenbach DJ, Jones RN, Lewis MT, Croco MA, Barrett MS.
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In-vitro activity of dirithromycin in comparison with other new and established macrolides.
    Bauernfeind A.
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():39-49. PubMed ID: 8478311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.